Overview
A comprehensive timeline of research efforts to identify the underlying causes and mechanisms of Gulf War illness (GWI) over three decades.
1990-1991: Deployment and Initial Outbreak
Approximately 700,000 U.S. troops deployed to the Persian Gulf leading a multinational coalition against Iraq. More than 25% of these soldiers returned home with a mysterious collection of chronic symptoms including fatigue, pain, memory/concentration problems, balance disturbances, exercise intolerance, diarrhea, skin rashes, and depression.
1997: First MRS Study
Dr. Robert Haley and colleagues at UT Southwestern used magnetic resonance spectroscopy (MRS) to examine the N-acetylaspartate (NAA)/total creatine (tCr) ratio in the basal ganglia of Gulf War veterans.
Findings: Veterans with GWI had a lower NAA/tCr ratio than those who served without developing GWI. However, MRS technology at the time could not distinguish whether this was due to relatively lower NAA or higher tCr — which have opposing implications: decreased NAA suggests nerve damage (incurable), while increased tCr suggests mitochondrial dysfunction.
2025: Breakthrough Study Published in Scientific Reports
Using state-of-the-art MRS equipment and techniques, researchers measured the NAA/tCr ratio in 39 Persian Gulf War veterans with GWI and 16 without. The lower ratio is definitively due to increased tCr, indicating mitochondrial dysfunction rather than neuronal damage.
Significance: This finding explains nearly all documented GWI symptoms through chronic neuroinflammation caused by mitochondrial dysfunction, suggesting potential for novel treatments that calm this inflammation.
Ongoing Research (2025)
Dr. Haley and colleagues are currently studying how low-level sarin gas exposure causes mitochondrial dysfunction — a key step toward developing targeted treatments.
---